Imad Shureiqi
Overview
Explore the profile of Imad Shureiqi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pudakalakatti S, Titus M, Enriquez J, Ramachandran S, Zacharias N, Shureiqi I, et al.
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163565
Peroxisome proliferator-activated receptor delta (PPARD) is a nuclear receptor known to play an essential role in regulation of cell metabolism, cell proliferation, inflammation, and tumorigenesis in normal and cancer cells....
12.
Yang P, Zuo X, Advani S, Wei B, Malek J, Day R, et al.
Cancer Prev Res (Phila)
. 2021 Oct;
15(4):217-223.
PMID: 34610992
Prevention Relevance: This study evaluated potential predictive biomarkers for celecoxib chemopreventive activity in patients with FAP. Our findings demonstrated the differential bioavailability of celecoxib between normal and polyp tissues and...
13.
Cata J, Patino M, Lacagnina M, Li J, Gorur A, Agudelo-Jimenez R, et al.
Pain Rep
. 2021 Jul;
6(2):e943.
PMID: 34235345
Introduction: Major advances in therapies to optimize recovery after surgery have been limited by the lack of an animal model that can mimic major domains of postoperative sickness behavior in...
14.
Leung M, Rogers J, Shureiqi I
Clin Colorectal Cancer
. 2021 May;
20(3):273-278.
PMID: 33965356
No abstract available.
15.
Liu F, Zuo X, Liu Y, Deguchi Y, Moussalli M, Chen W, et al.
Cell Rep
. 2020 Aug;
32(7):108049.
PMID: 32814052
APC mutation activation of Wnt/β-catenin drives initiation of colorectal carcinogenesis (CRC). Additional factors potentiate β-catenin activation to promote CRC. Western diets are enriched in linoleic acid (LA); LA-enriched diets promote...
16.
Jacome A, Kee B, Fogelman D, Dasari A, Shureiqi I, Raghav K, et al.
Clin Colorectal Cancer
. 2020 Jul;
19(4):248-255.e6.
PMID: 32665092
Introduction: It has been determined that right-sided metastatic colorectal cancer (mCRC) has a worse prognosis for overall survival (OS). Currently, there is no consensus on the best systemic regimen for...
17.
Advani S, Shi Q, Overman M, Loree J, Lam M, Morris V, et al.
Clin Colorectal Cancer
. 2020 Feb;
19(1):48-56.e2.
PMID: 32008976
Background: The survival of patients with metastatic colorectal cancer (mCRC) is influenced by the genetic and epigenetic changes that might influence the patient experience of symptom burden. Understanding the association...
18.
Korphaisarn K, Morris V, Davis J, Overman M, Fogelman D, Kee B, et al.
Br J Cancer
. 2019 Aug;
121(6):505-510.
PMID: 31406299
Background: Signet ring cell carcinoma (SRCC) is a rare subtype of colorectal cancer (CRC). The aim of this study was to characterise the genomic alterations and outcomes of SRCC. Methods:...
19.
Zuo X, Deguchi Y, Xu W, Liu Y, Li H, Wei D, et al.
Gastroenterology
. 2019 Mar;
157(1):163-178.
PMID: 30885780
Background & Aims: The peroxisome proliferator-activated receptor delta (PPARD) regulates cell metabolism, proliferation, and inflammation and has been associated with gastric and other cancers. Villin-positive epithelial cells are a small...
20.
Liu Y, Deguchi Y, Tian R, Wei D, Wu L, Chen W, et al.
Cancer Res
. 2019 Jan;
79(5):954-969.
PMID: 30679176
mutations activate aberrant β-catenin signaling to drive initiation of colorectal cancer; however, colorectal cancer progression requires additional molecular mechanisms. PPAR-delta (PPARD), a downstream target of β-catenin, is upregulated in colorectal...